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ABSTRACT  Sexually transmitted infections (STIs) are a major public health concern. The 
UK has some of the most advanced STI surveillance systems globally. This article uses national 
surveillance data to describe remarkable changes in STI epidemiology in the UK over the last 
century and explores the behavioral and demographic shifts that may explain these trends. 
The past 10 years have seen considerable improvements in STI service provision and the 
introduction of national public health interventions. However, sexual health inequalities 
persist and men who have sex with men, young adults and black ethnic minorities remain 
a priority for interventions. Technological advances in testing and a shift in sexual health 
service commissioning arrangements will present both opportunities and challenges in 
future.
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Sexually transmitted infections (STIs) are a major public health concern. They are etiologically, 
clinically and epidemiologically diverse: over 30 bacterial, viral and parasitic pathogens have been 
associated with sexual transmission. The WHO has estimated that, globally in 2008, there were 
almost 500 million new cases of four common curable STIs: Chlamydia trachomatis (chlamydia), 
Neisseria gonorrhoeae (gonorrhoea), Treponema pallidum (syphilis) and Trichomonas vaginalis (tricho-
moniasis) [1]. STIs are often considered stigmatizing and may seriously impact on the health and 
well-being of affected individuals, as well as being costly to healthcare services. Complications, 
which vary by infecting organism, include pelvic inflammatory disease (PID), epididymitis, infertil-
ity, ectopic pregnancy, cervical cancer, cardiovascular and neurological damage, adult mortality and 
fetal and neonatal morbidity and mortality [2]. Increasing resistance and decreased susceptibility to 
antimicrobials are emerging concerns, especially for gonorrhea [3–5].
Population characteristics, including population size, age structure, ethnic makeup and net migra-
tion, affect the epidemiology of STIs. In mid-2012, as context for this article, the UK population num-
bered an estimated 63.7 million across four constituent countries (England: 53.5 million; Scotland: 
5.3 million; Wales: 3.1 million; and Northern Ireland: 1.8 million) [6]. The UK population is aging, 
with a median age of 39 years [7], is growing due to net immigration and births exceeding deaths 
(0.7% growth in 2012), and is largely urban (82% in England and Wales). The largest ethnic group 
is white (86% in England and Wales), although the 8.2 m residents of London show far greater ethnic 
diversity, with 40% of the population being nonwhite and 37% born outside the UK [8,9]. In common 
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with other western European countries, the UK 
has also seen a dramatic rise in the proportion of 
adults who are single (35% in 2011 from 30% 
in 2001 in England and Wales) [10], a change in 
social circumstances that may underpin some of 
the changes in sexual behavior described below.
Overall, the epidemiology of STIs in the UK 
over the last century has been influenced by 
major social, economic and demographic shifts 
in society. Trends in reported STI diagnoses 
need to be interpreted with caution as their 
causes are multifactorial, reflecting changes in 
sexual attitudes and behaviors, as well develop-
ments in service provision, treatment, interven-
tions, diagnostic technologies and surveillance. 
Biological factors, such as transmission proba-
bility, infection duration and protective immu-
nity, also contribute to infection incidence and 
prevalence. In this article, we discuss historic 
and recent trends in the epidemiology of STIs 
(other than HIV) between 1922 and 2012 that 
are of particular public health concern in the 
UK. We focus on the population groups at great-
est risk, direct and contextual factors associated 
with transmission and recent developments in 
STI intervention and control.
STI service provision in the UK
The provision of sexual health services in the UK 
has evolved considerably over the past 20 years. 
The cornerstone of STI service provision is 
the network of NHS genitourinary medicine 
(GUM) clinics – free, confidential and open-
access sexual health services distributed across 
the UK that offer comprehensive, specialist STI 
testing and management services. However, 
an increasing proportion of STI-related care is 
provided by nonspecialist sexual health services, 
including general practice [11]. An important 
component of this shift has been the English 
National Chlamydia Screening Programme 
(NCSP), phased in across England from 2003 
[12]. The aim of the NCSP has been to reduce 
the prevalence of asymptomatic, undiagnosed 
chlamydial infections and associated infection 
sequelae by testing sexually active men and 
women under 25 years of age who attend a range 
of primary and community-based healthcare 
and nonhealthcare facilities. The proportion 
of STIs diagnosed outside the GUM clinic set-
ting varies by STI and the complexity of man-
agement required: in England, just over 50% 
of genital chlamydial infections are diagnosed 
in primary care and other community-based 
services [13], but it is likely that almost all syphilis 
is diagnosed and managed by GUM clinics.
Surveillance of STIs in the UK
The UK has some of the most advanced systems 
of STI surveillance globally. While specific sys-
tems vary across the four countries of the UK, all 
use similar approaches and sources of data. Data 
in this article are presented for the UK wher-
ever possible but, where not available, they are 
presented for specific countries within the UK.
GUM clinics are an important source of STI 
surveillance data. They provide pseudonymized, 
patient-level data on STI-related services and 
diagnoses for local and national surveillance, 
often including patient-level sociodemographic 
and some behavioral information. For example, 
the GUM Clinic Activity Dataset (GUMCAD) 
is a mandatory national statistical return that 
collects data on all patient attendances at GUM 
clinics in England every calendar quarter, and 
similar systems exist in Scotland (the National 
Sexual Health System [NaSH]) and Wales (the 
Sexual Health in Wales Surveillance System 
[SWS])  [14–18]. These data provide unique 
insights, particularly into the incidence and 
distribution of STIs in the UK and risk factors 
associated with their acquisition. The availabil-
ity of linked patient records enables longitu-
dinal analyses in order to assess sexual health 
outcomes in specific population groups.
Disaggregated data reports from laboratories 
are another important source of information on 
STI diagnoses [16,18–21]. While laboratory reports 
provide more limited information on patient risk 
factors, they provide a more comprehensive pic-
ture of diagnoses made regardless of the service 
provider. Efforts to collect more detailed clinical 
data from nonspecialist settings offering sexual 
health services, such as contraceptive and repro-
ductive health services and ‘enhanced’ general 
practices, are also underway across most of the 
UK [15,16,18].
Enhanced surveillance systems have also been 
developed in order to monitor specific arising 
public health concerns. For example, England, 
Wales and Scotland have established systems 
for monitoring resistance and the emerging 
decreased susceptibility of gonorrhea to antimi-
crobials, which is now considered to be a global 
public health priority [5,22,23]. These systems 
enable the detection of emerging antimicrobial 
resistance patterns and the demographic and 
behavioral risk characteristics associated with 37
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their spread. An enhanced UK-wide national 
surveillance system for Lymphogranuloma 
venereum (LGV) was established in 2004 fol-
lowing outbreaks in western Europe among men 
who have sex with men (MSM) and has been 
used to understand the groups affected by LGV 
and to develop infection control programs [24–27].
However, all of these surveillance systems 
monitor trends in diagnosed infections in those 
attending services for care. Many STIs are fre-
quently asymptomatic and may not be diagnosed 
or may not result in people seeking care, such 
that case-based surveillance systems can under-
estimate the underlying prevalence of STIs in 
the population and how this relates to behavio-
ral risk. Our understanding of sexual behavior 
and STI prevalence in the UK at a population 
level has been uniquely informed by three con-
secutive National Surveys of Sexual Attitudes 
and Lifestyles (Natsal) performed a decade 
apart since 1990, which represent some of the 
largest, most comprehensive studies of sexual 
behavior anywhere in the world and include 
over 45,000 participants born between 1930 
and 1990 [28,29]. As well as monitoring changes 
in sexual behavior and access to sexual health 
services, the Natsal studies have used biological 
sampling to provide robust prevalence estimates 
for key STIs in the general population [28–31].
STIs of public health importance in the UK
STIs warrant particular public health atten-
tion. Untreated infection can result in serious 
long-term morbidity and mortality, can impact 
on female fertility and can facilitate HIV trans-
mission. While some infections are relatively 
prevalent and geographically widespread, oth-
ers are rare in the general population but can 
be locally prevalent in specific population core 
groups. The following section provides a public 
health summary for the most important STIs 
in the UK.
● ● Chlamydia
Genital chlamydial infection is the most com-
monly diagnosed bacterial STI in the UK and is 
caused by infection with C. trachomatis. Infection 
is readily treated with antibiotics. There were 
almost 240,000 diagnoses in the UK in 2012 [13] 
and, despite considerable increases in chlamydia 
testing in recent years [16,18,32], it is likely that 
many infections are undiagnosed and untreated. 
Younger adults aged under 25 years are most 
affected, in whom estimated prevalence ranges 
between 2 and 3% in the general population [30,31] 
and up to 10% in those attending chlamydia test-
ing services [33,34]. Most infections are asympto-
matic and an estimated 16% of untreated cases 
may result in clinical PID [35], which may lead to 
infertility and other complications.
● ● Human papillomavirus
There are more than 30 types of sexually trans-
mitted human papillomavirus (HPV), which 
is the most prevalent STI in the UK. Infection 
with high-risk HPV types, particularly 16, 18, 
31 and 45, may lead to the development of inva-
sive cervical cancer and other cancers of the ano-
genital tract [36], while infection with low-risk 
HPV types, particularly 6 and 11, can cause 
genital warts. Among those aged 10–49 years, 
the prevalence of HPV types 6 and 11 has been 
estimated to be approximately 16% and 6% in 
women and 8% and 2% in men, respectively 
[37]. The prevalence of high-risk HPV types is 
approximately 16% in women and 8% in men 
aged 16–44 years, but can be considerably higher 
in high-risk groups, such as HIV-positive MSM 
[30,38]. There are just under 90,000 diagnoses 
of first episodes of genital warts made in GUM 
clinics in the UK each year [13,16,18,19]. Although 
warts are readily treatable, recurrent presenta-
tions are common and make up over 40% of 
total diagnoses of genital warts [13].
● ● Genital herpes
Genital herpes is the most common ulcerative 
STI in the UK, with approximately 34,000 first 
episodes diagnosed and reported in the UK 
each year [13,16,18–19]. It is caused by infection 
with herpes simplex virus (HSV) types 1 and 2. 
Approximately half of genital HSV in women 
and a third in men is caused by type 1, which also 
causes oral herpes [39,40]. HSV-2 antibody preva-
lence in England and Wales has been estimated 
to be approximately 5% in women and 3% in 
men [41]. As with genital warts, recurrent pres-
entations are common and make up over 40% of 
the total diagnoses of genital HSV [13], although 
their frequency and severity wanes over time [42]. 
Although antiviral treatment can reduce the 
duration and severity of herpetic symptoms and 
daily prophylaxis may control recurrences, HSV 
infection is lifelong.
● ● Gonorrhea
Gonorrhea, caused by infection with the Gram-
negative diplococcus N. gonorrhoeae, is the Future Microbiol. (2015) 10(1) 38
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Figure 1. Diagnoses of gonorrhea and syphilis in England, Wales and Scotland (see facing page). (A) Diagnoses of gonorrhea1922 to 
2012. (B) Diagnoses of syphilis1945 to 2012.  
Data from GUM service returns. Data taken from Public Health England © Crown copyright 2014. 
For color figures, please see online at http://www.futuremedicine.com/doi/full/10.2217/FMB.14.110 
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second most common bacterial STI in the UK, 
with nearly 29,000 diagnoses in 2012 [13]. It is 
the most commonly diagnosed STI among MSM 
and rates are highest in black ethnic minorities. 
Genital infection in men is usually symptomatic, 
but approximately half of cases in women are 
asymptomatic. In contrast to chlamydial infec-
tion, gonorrhea is rare in the general population 
(prevalence below 0.1%) [30]. Due to its rela-
tively short duration of infectiousness, gonor-
rhea is concentrated geographically in specific 
subgroups of the population that have higher 
rates of partner change, partnership concurrency 
or where there is particularly poor access to treat-
ment [43]. Although treatable with antibiotics, 
the emergence of resistance and reduced suscep-
tibility to successive antimicrobial agents is of 
global concern, requiring two revisions to the 
UK national gonorrhoea treatment guideline in 
the past 10 years [44].
● ● Syphilis
Syphilis is a relatively rare bacterial infection 
in the UK that is caused by the spirochaete 
T. pallidum. Early infectious syphilis is readily 
treated with antibiotics. Although rare, it has 
been associated with localized outbreaks among 
those in high-risk sexual networks. There were 
3300 diagnoses of early infectious syphilis in 
the UK in 2012, of which 91% were in men, the 
majority of whom were MSM [13,32]. However, a 
significant proportion of syphilis cases are diag-
nosed late [13]. Due to comprehensive antenatal 
screening for syphilis infection in the UK, cases 
of congenital syphilis remain rare, although 
reported cases have been increasing in recent 
years [45,46].
● ● Lymphogranuloma venereum
LGV is caused by infection with the ‘L’ biovars 
(L1, L2 and L3) of C. trachomatis. LGV was 
rare across western Europe, including in the UK, 
until the early 2000s. However, a series of out-
breaks of LGV emerged among MSM in Europe 
in 2003 [47]. By 2013, almost 3000 LGV diag-
noses had been made in the UK, which now has 
the largest documented outbreak globally [26]. 
The great majority of cases present with proc-
titis, which is readily treatable with antibiotics; 
however, late-presenting cases have led to severe 
complications [25].
● ● Trichomoniasis
Trichomoniasis, caused by the protozoan 
T. vaginalis, is a relatively uncommon infec-
tion in the UK, and infection tends to be clus-
tered in specific urban areas, especially London 
and Birmingham, and among black ethnic 
minorities [48]. In England in 2012, there were 
6600 diagnoses, over 90% of which were in 
women, reflecting the longer duration of infec-
tion in women [49]. It is readily treated with anti-
protozoals. However, because many infections 
are subclinical, it is likely that infections remain 
undiagnosed in some population groups.
● ● Other STIs
Other STIs commonly diagnosed in GUM 
clinics include molluscum contagiosum (a pox-
virus), pediculosis pubis (caused by infection 
with the pubic louse Pthirus pubis) and scabies 
(caused by infection with the mite Sarcoptes 
scabiei). There are approximately 14,000 diag-
noses of these infections made in GUM clinics 
in England every year [13]. In addition, sexual 
transmissions of hepatitis B (HBV) virus, hepa-
titis C virus (HCV) and gastrointestinal infec-
tions such as Shigella flexneri and Shigella sonnei 
are reported periodically among MSM, often 
detected through outbreak investigations [50–54]. 
However, HBV infection is now less common in 
UK MSM due to high vaccination coverage at 
GUM clinics [55].
Historical trends
There have been remarkable changes in the 
epidemiology of STIs in the UK over the past 
century (Figure 1). While data were unreliable 
in the early 1900s, the morbidity and mortal-
ity associated with syphilis in particular were 
likely to be considerable. In 1913, this led the 
Government to set up a Royal Commission 
on Venereal Diseases, which recommended 
the establishment of a network of a free, open-
access treatment services, implemented through 
the Public Health (Venereal Diseases) Act of 
1917 [56]. Between 1918 and 1919, diagnoses of 
syphilis rose from 27,000 to 42,000, and those Future Microbiol. (2015) 10(1) 40
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of gonorrhea from 17,000 to 38,000, reflecting 
the return of the armed forces at the end of the 
First World War. Following a period of modest 
decline and stability, numbers increased again 
at the end of the Second World War, reaching 
18,000 syphilis and 54,000 gonorrhea diagno-
ses by 1946. The mass production and availabil-
ity of penicillin at the end of the 1940s and a 
return to social stability probably led to the rapid 
decline in diagnoses immediately thereafter, to 
900 syphilis and 20,000 gonorrhea diagnoses 
by 1954 [56].
However, this decline was short lived. During 
the 1960s, major social changes led to greater 
sexual liberation, facilitated by the availability of 
the oral contraceptive pill and the decriminaliza-
tion of homosexual acts in men that occurred in 
the UK in 1967. These changes coincided with 
a steady rise in STIs, and by 1969, numbers of 
diagnoses of gonorrhea exceeded the postwar 
peak (Figure 1). In contrast to gonorrhea diagno-
ses, which rose sharply in both men and women, 
diagnoses of syphilis increased only in men, sug-
gesting sex between men was the primary driver 
of syphilis transmission during this period.
Extensive media coverage and national public 
health campaigns following the emergence of 
HIV and AIDS during the 1980s, which likely 
led to behavioral modification and a significant 
reduction in STI transmission [57]. Between 1985 
and 1988, diagnoses of gonorrhea fell by 63% 
and those of syphilis by two-thirds (Figure 1). 
Over the same period, diagnoses of genital her-
pes and genital warts, which had been steadily 
rising since recording began in 1972, also sta-
bilized or declined [57]. Numbers of gonorrhea 
and syphilis diagnoses remained at historically 
low levels until the mid-1990s, suggesting that 
the impact of the HIV epidemic and associ-
ated changes in sexual behavior may have been 
sustained for at least 10 years.
Recent epidemiology & trends
● ● Distribution
STIs are highly unequally distributed in popula-
tions and geographically, reflecting variations in 
the distributions of populations at risk, sexual 
behavior and activity, access to diagnosis and 
treatment services, healthcare-seeking behav-
ior and biological factors, including transmis-
sion probability and infection duration. Those 
who are affected often belong to more mar-
ginalized populations in society, often termed 
‘core groups’. In the UK, as in many western 
industrialized countries, STIs disproportionately 
affect young people aged under 25 years, MSM 
and certain black ethnic minority populations.
Geographic distribution
STIs are geographically concentrated. In 
2012, overall STI rates in Local Government 
Authorities in England ranged from <90 to 
>3000 per 100,000 of the population. Rates 
of diagnosis are typically higher in more urban 
areas, with rates highest in London, largely 
reflecting the distribution of core groups of the 
population who are at greatest risk of infec-
tion (Figure 2). There is also a strong positive 
association between STI rate and area-level 
deprivation [58,59]. These patterns are sugges-
tive of enhanced STI transmission among geo-
graphically clustered, densely connected sexual 
networks [58,59].
Young adults
Young adults, typically those aged 15–24 years, 
experience the highest rates of infection. These 
age distributions reflect sexual mixing patterns 
and levels of sexual activity in the population. 
Young adults report higher numbers of partners 
than older adults, and may also be less skilled at 
negotiating and maintaining effective condom 
use [29,60]. The third Natsal study (Natsal-3) 
showed that, in Britain between 2010 and 2012, 
approximately 9% of women and 15% of men 
aged 16–74 years reported two or more partners 
in the past year, but this proportion was 27% 
of women and 34% of men among those aged 
under 25 years [29]. Similarly, having two or more 
sexual partners without condoms in the past 
year, a key risk factor for STI acquisition and 
a measure of unsafe sex used in Natsal-3, was 
reported by 16% of men aged 16–24 years com-
pared with 7% of those aged 16–74 years, and 
by 14% of women aged 16–24 years compared 
with 5% of those aged 16–74 years [29]. STI rates 
in women increase sharply from 15 years of age 
and, for chlamydia, genital warts and gonorrhea, 
peak at approximately 19 years of age, declining 
sharply in women by their early- to mid-thirties 
(Figure 3) [18]. The age distribution in men is simi-
lar, although rates tend to peak in men in their 
early- to mid-twenties and with higher rates per-
sisting into older ages, partly reflecting diagnoses 
among MSM (Figure 3) [18]. In 2012, between a 
half and two-thirds of heterosexuals diagnosed 
with chlamydia, genital warts and gonorrhea in 
GUM clinics in England were aged 15–24 years. 41
Figure 2. Range in rates of sexually transmitted infection diagnoses in 326 local government authority areas of residence in 
England, 2012. 
Data from GUM service returns. Data taken from Public Health England © Crown copyright 2014. 
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In the same year in Scotland, approximately 
three-quarters of genital chlamydia and gonor-
rhea diagnoses in women were made in those 
aged under 25 years [39].
Repeat infection can contribute significantly 
to infection persistence in a population and 
is particularly common among adolescents 
and young adults [61]. Approximately 11% of 
16–19-year-old women and 12% of 16–19-year-
old men with a STI become reinfected within 
1 year [62].
Men who have sex with men
MSM are disproportionately affected by STIs. 
MSM tend to report higher rates of partner 
change than heterosexual populations and they 
are more likely to belong to complex, densely 
connected sexual networks that facilitate rapid 
STI transmission [63]. Although only 2.6% of the 
male British population reported a male partner 
in the past 5 years [29], in England in 2012, 
approximately 79% of syphilis, 58% of gonor-
rhea and 17% of chlamydia diagnoses in men 
in GUM clinics were in MSM [32]; in the UK, 
LGV is diagnosed almost exclusively in MSM 
[26]. STI diagnoses in MSM are concentrated 
in urban areas, especially London, Manchester 
and Brighton [26,32]. In 2010–2012, over a half 
of syphilis diagnoses and two-thirds of LGV 
diagnoses among MSM were in London [13,26].
Some MSM may also adopt HIV seroadap-
tive behavioral strategies, whereby men choose 
to have unprotected sex (sex without condoms) 
with partners according to their perceived HIV 
infection status, with the intention of reducing 
HIV transmission risk [63]. Seroadaptive behav-
iors increase exposure to STIs (as well as lead to 
unintended HIV transmission) and have been 
associated with recent STI epidemics in MSM 
in the UK, including LGV, HCV and S. flexneri 
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Figure 3. Age distribution of selected sexually transmitted infections (rate/100,000) diagnosed in England, 2012 (see facing page). 
(A) Women. (B) Men. 
†First episode.  
Data from GUM service returns. Data taken from Public Health England © Crown copyright 2014. 
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[26,53,64]. Among MSM, approximately 80% of 
those diagnosed with LGV, 60% diagnosed with 
S. flexneri and almost a third diagnosed with 
syphilis are HIV positive [14,26,64]. HIV-positive 
MSM are also at greatly increased risk of HPV-
related disease, including anal cancer [65]. In one 
UK study of immunosuppressed HIV-positive 
MSM, 84% had high-risk HPV types and 
11% had associated cytological abnormalities 
detected [66].
Black ethnic minorities
Recent surveillance data from England indicate 
that black ethnic minorities and especially black 
Caribbean populations are at much greater risk 
of STIs, especially for gonorrhea and tricho-
moniasis, for which they have a 12- to 20-fold 
greater risk compared with the general popula-
tion (Figure 4) [48,67]. Black Caribbean popula-
tions also experience the highest rates of repeat 
gonococcal infection, with approximately 12% 
of those diagnosed with gonorrhea presenting 
with a reinfection within 1 year [59]. Among 
other factors, this inequitable distribution is 
probably influenced by health service provi-
sion and access, health awareness and health-
care-seeking behavior [68]. Although somewhat 
reduced, the inequity persists after adjustment 
for socioeconomic deprivation, suggesting that 
other cultural influences on sexual behavior are 
likely to contribute to STI risk [48,67]. Natsal-2, 
but not Natsal-3, included additional sampling 
of ethnic minority groups and found strong 
evidence of higher numbers of lifetime partners 
among black ethnic minorities, who were also 
more likely to report STI diagnoses in the past 
5 years when compared with white men and 
women [69]. Concurrent sexual partnerships and 
cultural barriers to condom use may contribute 
to high STI rates among black Caribbeans [70].
Sex workers
Sex workers (SWs) are often considered to be 
at particular risk of STIs, although in England, 
female SWs attending GUM clinics are only 
at marginally higher risk of an STI than other 
female attendees [71]. This is despite a high 
proportion being migrants and potentially 
‘harder-to-reach’. However, there is evidence 
of geographic variation in access to services, 
and street-based SWs in particular may experi-
ence considerable health inequalities, drug- and 
alcohol-dependency problems and poor access to 
testing services [72]. Furthermore, STI outbreaks 
can easily emerge and spread in this vulnerable 
population [73]. Male SWs are also likely to be 
at increased risk of STIs, HIV and mental ill 
health [74]. In 2011, 2704 female and 488 male 
SWs attended a GUM clinic in England [74,75].
● ● Recent trends
By the late 1990s, rates of STI diagnoses were 
again increasing rapidly and, with few excep-
tions, have continued to rise until 2012. In the 
last 10 years, numbers of new STI diagnoses in 
England rose by 47%, from 305,000 to 448,000 
[13]. Almost half a million STI diagnoses are now 
made in the UK annually [62].
The most remarkable changes were observed 
for diagnoses of genital chlamydial infection, 
which have more than doubled in the last 
10 years and now comprise 46% of all STI 
diagnoses in England [32]. Diagnoses of genital 
HSV also nearly doubled over the same period 
[32]. In the last 5 years, gonorrhea diagnoses in 
the UK rose by 74%, and by 24% in the last 
year alone [13]. While diagnoses of most other 
STIs also rose during this period, the changes 
were far less pronounced; for example, reported 
cases of infectious syphilis rose by 14% in the 
UK between 2008 and 2012 [13]. In the case of 
genital warts, between 2011 and 2012, new diag-
noses declined in England by 3%, but increased 
in Wales by 10% [18,32].
While numbers of diagnoses of most STIs 
have been increasing in men and women, the 
most notable increase in numbers has been 
among MSM in the last 5 years, especially for 
chlamydia and gonorrhea (Figure 5). In parallel, 
new diagnoses of LGV in MSM and reports 
of nontravel-related S. flexneri 3a infections in 
adult males, which is suggestive of transmission 
among MSM, grew exponentially [26,51]. Of par-
ticular concern has been the recent rapid emer-
gence of decreased susceptibility of gonorrhea to 
cefixime in MSM in England and Wales, which 
precipitated a change in the national gonorrhea 
treatment guideline in 2011 [44,76]. Prior to this, Future Microbiol. (2015) 10(1) 44
Figure 4. Rates of selected sexually transmitted infections diagnosed in England stratified by 
ethnic group, 2012. 
†First episode. 
‡Primary, secondary and early latent. 
 Data taken from Public Health England © Crown copyright 2014. 
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the rapid emergence of quinolone resistance 
among MSM in the early 2000s had resulted in 
a treatment guideline change in 2005 [77].
The drivers of these recent trends in STI diag-
noses are complex and multifactorial. In part, 
they reflect increased infection incidence and 
prevalence associated with changes in sexual 
behavior and exposure to infection, influenced 
by intrinsic biological factors [43,78]. However, 
they are also associated with improvements in 
service access, STI testing interventions and 
testing technologies that have facilitated better 
infection detection. The drivers of STI trends 
are discussed in detail below.
Sexual behavior
In common with other western European coun-
tries, in Britain, there has been a fall in the age 
at first sex over many decades, from a median 
of 18 years of age in men and 19 years of age in 
women born in the 1940s, to 16 years of age in 
men and women born in the 1990s [29]. At the 
same time, there have been substantial increases 
for men and women in the time between each 
of first sex, first live-in relationship and having 
children, with the result that young adults are 
likely to spend longer at risk of STIs [79]. In part, 
this may explain the rise in the number of lifetime 
partners reported by men and women [29].
In 2000, Natsal-2 documented dramatic 
increases in many reported behaviors compared 
with 1990 [80]. It is likely that these changes in 
sexual behavior between 1990 and 2000 facili-
tated STI transmission and contributed to the 
substantial increases in STI diagnoses recorded 
during this period. The early 1990s probably 
represented a period of low sexual risk behavior 
coinciding with wide public concern regarding 
HIV. However, the most recent Natsal-3 study 
found only moderate changes in reported sexual 
behaviors in Britain between 2000 and 2010, 
and the increases in STI diagnosis rates in het-
erosexuals during this period are more difficult 
to explain [29].
For MSM, however, a rather different and 
more complex picture is evident. Approximately 
3% of the male population in Britain report at 
least one male sexual partner in the past 5 years, 
and this proportion has not changed since 2000 
[29]. Unfortunately, national probability samples 45
Figure 5. Diagnoses of selected sexually transmitted infections in men who have sex with me in England, 2003-2012.  
†First episode. 
‡Nonspecific genital infection. 
§Primary, secondary and early latent. 
Data taken from Public Health England © Crown copyright 2014. 
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contain insufficient numbers of MSM to reliably 
explore behaviors within this population, such 
as the proportion reporting unprotected anal 
intercourse. Surveys of gay commercial venues 
and gyms in London, Glasgow and Edinburgh 
suggest complex patterns of behavior, but pro-
vide evidence of overall increases in the propor-
tion reporting unprotected anal intercourse with 
partners of unknown or discordant HIV status 
[81,82]. These changes are consistent with the 
adoption of HIV seroadaptive behaviors among 
a growing population of HIV-positive MSM on 
antiretroviral therapy [63,83], facilitated through 
web-based apps for meeting sexual partners 
[26]. The rapid increase in the number of chla-
mydia and (especially rectal) gonorrhea diagno-
ses, the emergence of gonococcal isolates with 
decreased susceptibility to cefixime, the evidence 
of sexually transmitted HCV and the ongoing 
LGV and S. flexneri epidemics strongly suggest 
that these changes in behavior and practices are 
leading to greater STI incidence among MSM, 
and especially HIV-positive MSM, in dense sex-
ual networks [14,26,27,44,51,53,54]. Intensive recrea-
tional drug use may also be facilitating increased 
STI transmission in some cases [64].
Service access & interventions
Sexual health services in the UK have evolved 
considerably since the beginning of the 21st 
century. This has enabled improved access to 
a broader range of services offering STI testing 
and sexual healthcare and has led to an increase 
in diagnoses of many STIs.
There has been a dramatic rise in the num-
ber of people accessing sexual health clinics. By Future Microbiol. (2015) 10(1) 46
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2010, approximately one in five Britons aged 
16–44 years reported clinic attendance in the 
previous 5 years, an increase from approximately 
one in 14 in 2000 [30]. Improvements in service 
availability and choice, including enhancement 
of sexual health services offered through pri-
mary care, have likely facilitated better access 
to care [11,84–86]. In parallel, the introduction of 
government targets to reduce waiting times at 
GUM clinics to 48 h in England is likely to have 
increased patient throughput [87].
This increased service capacity enabled more 
STI testing, and the numbers of STIs tests 
reported in England, Wales and Scotland have 
risen sharply in recent years [16,18,32] Between 
2003 and 2012 in England, STI tests conducted 
in GUM clinics almost doubled from 633,000 
to 1,241,000 [88], while between 2007 and 
2012 in Wales, STI tests conducted in sexual 
health clinics rose by nearly two-thirds to reach 
41,000. Most notable has been the increase in 
testing for genital chlamydial infection. While 
this has occurred across the UK, it has been 
most pronounced in England following the 
introduction of the English NCSP [32]. As a 
result of this program, national surveillance 
data indicated over 1.7 million young adults 
in England were tested for chlamydia, which 
is equivalent to a testing coverage of 35% of 
young women and 16% of young men and with 
a positivity of between 7 and 9% [32]. Data from 
Natsal-3 suggest that among those who were 
sexually active, 54% of women and 35% of 
men aged 16–24 years had a chlamydia test in 
the past year [30] and that testing was broadly 
higher in those reporting risky behaviors [89]. 
Nevertheless, 54% of men and 30% of women 
aged 16–24 years with two or more partners 
in the past year had not been tested and a 
substantial proportion of infections remained 
undiagnosed [30,89].
These increases in testing frequency have 
occurred alongside and have been facilitated 
by rapid developments in molecular testing 
technology, especially for chlamydia, gonor-
rhea and genital HSV, which have improved 
test sensitivity and specificity while using less 
invasive specimens [90–92]. Increased detection of 
asymptomatic infection has made a significant 
contribution to the rapid increase in diagnoses 
made among young adults, MSM and those 
attending GUM clinics in general. More testing 
of specimens from the rectum and pharynx have 
further improved the detection of gonococcal 
and chlamydial infections in MSM, leading to 
higher numbers of diagnoses [32].
However, the earlier detection and treatment 
of STIs following these improvements in ser-
vice provision should, in time, lead to reduced 
STI transmission and fewer numbers of diag-
nosed infections and associated morbidity [93]. 
Diagnoses of PID among women in the UK have 
declined rapidly in recent years, but particularly 
in the youngest age groups [94]. Although a mat-
ter of some debate, the sharp reduction in PID 
diagnoses in young adults may in part be associ-
ated with increased chlamydia testing coverage 
in this age group [95].
In contrast to other STIs, diagnoses of geni-
tal warts in teenagers have begun to decline in 
the last few years. In England, diagnoses among 
women aged 15–19 years fell by 22% between 
2009 and 2012 [32]. The UK introduced a 
school-based HPV immunization program in 
September 2008 targeting 12-year-old girls and 
initially including a catch-up program for girls 
aged up to 18 years [96]. Coverage of over 80% 
among 12-year-olds has been achieved and the 
prevalence of high-risk HPV types 16 and 18 is 
already in decline [97]. However, unlike many 
countries, the UK’s program initially used the 
bivalent vaccine that only targets HPV types 
16 and 18, and was not expected to impact on 
genital warts diagnoses. In fact, there is now 
increasing evidence that the HPV-16/18 vacci-
nation program has been moderately protective 
against genital warts [98,99]. A further, more rapid 
decline in genital warts is now anticipated, as 
the UK program has recently switched to the 
quadrivalent vaccine, which also targets HPV 
types 6 and 11 [96].
Conclusion
Infectious disease epidemiology is complex 
and this is especially so for STI epidemiology, 
which is uniquely linked to sexual contact. The 
dynamic interplay between underlying STI 
prevalence, sexual behavior, service access and 
public health interventions drives trends in STI 
diagnoses and complicates their interpretation. 
It may take several years for the effects of an 
intervention or changes in population-level 
behavior to become apparent, and routine and 
regular assessments of STI epidemiology using 
high-quality surveillance systems supported by 
population-based surveys and mathematical 
modeling have been vital to understanding their 
impact in the UK. While sexual behavior has not 47 future science group www.futuremedicine.com
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changed significantly at the general population 
level in recent years, the persisting high inci-
dence of STIs in young adults, MSM and black 
Caribbean populations requires a continuing 
public health focus and further research in order 
to develop effective, evidence-based interven-
tions. Across the UK, the last decade has seen a 
strengthening of sexual health and STI services, 
EXECUTivE SUMMARY
Sexually transmitted infection service provision in the UK
  ●   The provision of sexual health services in the UK has evolved considerably over the past 20 years.
  ●   Genitourinary medicine clinics offer comprehensive, specialist sexually transmitted infection (STI) testing and 
management services; however, an increasing proportion of STI-related care is provided by nonspecialist sexual health 
services.
Surveillance of STIs in the UK
  ●   Disaggregated genitourinary medicine clinic data provide insights into the incidence and distribution of STIs in the UK 
and the risk factors associated with their acquisition.
  ●   STI surveillance is being improved by the increased collection of data from nonspecialist settings, including general 
practice.
  ●   Surveillance data have been complemented by three consecutive National Surveys of Sexual Attitudes and Lifestyles 
studies, which have monitored changes in sexual behavior and access to sexual health services and used biological 
sampling in order to provide robust estimates of STI prevalence in the general population.
STIs of public health importance in the UK
  ●   Human papillomavirus is the most prevalent STI, with high-risk types detected in 16% of women and 8% of men aged 
16–44 years.
  ●   Genital chlamydia is the most common bacterial STI, with a prevalence in adults aged under 25 years of between 2 and 
3% in the general population and up to 10% in those attending testing services.
  ●   Gonorrhea and syphilis are relatively rare in the UK, but can be locally common in high-risk populations.
  ●   Lymphogranuloma venereum has emerged alongside other sexually transmissible infections, such as hepatitis C virus 
and Shigella flexneri, as a significant public health concern in men who have sex with men (MSM).
Historical trends
  ●   Cases of gonorrhea and syphilis rose sharply at the end of the Second World War with the return of the armed forces, 
but declined rapidly with the availability of penicillin and the return to social stability.
  ●   Major social, medical and legal changes during the 1960s coincided with a steady rise and subsequent stabilization in 
STI diagnoses, which persisted until the mid-1980s.
  ●   The emergence of the HIV and AIDS during the 1980s led to behavioral modification and a sharp decline in diagnoses, 
which persisted until the mid-1990s.
Recent epidemiology & trends
  ●   Young people aged under 25 years, MSM and certain black ethnic minority populations experience the highest rates of 
infection.
  ●   STI diagnoses have risen considerably in the last 10 years, and almost half a million STI diagnoses are now made in the 
UK annually.
  ●   This rising trend partly reflects major improvements in service access and testing interventions, such as the 
implementation of the National Chlamydia Screening Programme in England, which have led to greater numbers of 
infections being diagnosed.
  ●   Changes in sexual behavior among MSM, especially HIV-seroadaptive behaviors, have probably led to the increased 
incidence and prevalence of STIs in this population.Future Microbiol. (2015) 10(1) 48
REviEW  Hughes & Field
future science group
which will have brought significant improve-
ments in service access and to sexual health in 
the population.
Future perspective
In the future, new molecular testing technolo-
gies, such as multiplex and point-of-care tests, 
may improve access and facilitate prompt treat-
ment, but their use will require appropriate stew-
ardship in order to discourage unnecessary test-
ing, false-positive results and consequent harm 
[100]. Major revisions to the commissioning and 
provision of sexual health services, especially in 
England, raise opportunities for STI control to 
be prioritized by local government, but equally 
present challenges, such as the potential frag-
mentation of services [101]. The effects of these 
changes on service access, service provision and 
quality of care, the size and behavior of at-risk 
populations, the impact of population-level 
interventions and evolving testing technologies 
will shape STI epidemiology in the UK over the 
coming decade.
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